IRIS
DEROSA, GIUSEPPE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 28.975
AS - Asia 18.856
EU - Europa 14.677
SA - Sud America 2.494
Continente sconosciuto - Info sul continente non disponibili 657
AF - Africa 578
OC - Oceania 39
Totale 66.276
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 27.839
CN - Cina 10.110
SG - Singapore 4.008
IE - Irlanda 2.946
UA - Ucraina 2.542
DE - Germania 2.076
BR - Brasile 1.836
HK - Hong Kong 1.689
FI - Finlandia 1.686
IT - Italia 1.486
VN - Vietnam 1.356
RU - Federazione Russa 1.246
FR - Francia 821
SE - Svezia 804
GB - Regno Unito 540
CA - Canada 456
IN - India 354
BD - Bangladesh 273
ZA - Sudafrica 268
AR - Argentina 206
IQ - Iraq 154
MX - Messico 133
NL - Olanda 118
EC - Ecuador 111
TR - Turchia 105
JP - Giappone 100
CR - Costa Rica 97
ID - Indonesia 91
CO - Colombia 83
PK - Pakistan 82
VE - Venezuela 72
TT - Trinidad e Tobago 67
NI - Nicaragua 66
ES - Italia 65
MA - Marocco 64
PL - Polonia 58
UZ - Uzbekistan 57
PH - Filippine 56
PR - Porto Rico 54
HN - Honduras 50
SA - Arabia Saudita 50
CL - Cile 49
MY - Malesia 48
SV - El Salvador 48
EG - Egitto 47
PE - Perù 47
CW - ???statistics.table.value.countryCode.CW??? 46
GT - Guatemala 44
TN - Tunisia 43
JM - Giamaica 42
KE - Kenya 40
IL - Israele 39
JO - Giordania 38
PY - Paraguay 36
BE - Belgio 32
IR - Iran 32
BO - Bolivia 27
RO - Romania 27
GP - Guadalupe 26
LT - Lituania 25
TH - Thailandia 23
AL - Albania 22
GR - Grecia 22
KZ - Kazakistan 21
AE - Emirati Arabi Uniti 20
UY - Uruguay 20
AZ - Azerbaigian 19
CH - Svizzera 19
NP - Nepal 19
AT - Austria 18
AU - Australia 18
DZ - Algeria 18
ET - Etiopia 18
MU - Mauritius 18
PA - Panama 17
NZ - Nuova Zelanda 16
DO - Repubblica Dominicana 15
EU - Europa 15
KG - Kirghizistan 15
CZ - Repubblica Ceca 14
EE - Estonia 14
SC - Seychelles 13
BH - Bahrain 12
PT - Portogallo 12
HU - Ungheria 11
MK - Macedonia 11
SN - Senegal 11
KR - Corea 9
OM - Oman 9
QA - Qatar 9
RS - Serbia 9
KW - Kuwait 8
MD - Moldavia 8
AM - Armenia 7
DK - Danimarca 7
BB - Barbados 6
BG - Bulgaria 6
CI - Costa d'Avorio 6
GE - Georgia 6
LV - Lettonia 6
Totale 65.558
Salva come PNG Salva come JPEG
Città #
Jacksonville 3.402
Dublin 2.944
Chandler 2.846
San Jose 2.743
Nanjing 2.513
Ashburn 2.004
Singapore 1.875
Dallas 1.644
Hong Kong 1.640
Council Bluffs 1.413
Boardman 1.104
Nanchang 1.092
Beijing 976
Princeton 810
Shenyang 768
Hebei 702
Lawrence 701
Changsha 685
Wilmington 658
Lauterbourg 633
Jiaxing 575
Los Angeles 538
Munich 537
Medford 521
Ho Chi Minh City 465
Hangzhou 433
Tianjin 426
Helsinki 419
Hanoi 341
Redondo Beach 302
Buffalo 277
New York 267
Santa Clara 235
Milan 233
Johannesburg 229
Moscow 203
São Paulo 181
Toronto 159
Shanghai 149
Ann Arbor 138
Seattle 131
Woodbridge 116
Norwalk 115
Atlanta 102
Orem 100
Montreal 96
Tokyo 91
Rome 83
San Francisco 83
Brooklyn 81
Fairfield 80
Jinan 77
Turku 77
Chicago 74
Baghdad 70
Des Moines 69
Frankfurt am Main 69
Kunming 69
Managua 66
Phoenix 66
San José 65
Da Nang 63
Cambridge 62
Guangzhou 60
Chennai 58
Rio de Janeiro 58
Quito 54
Ningbo 52
North Bergen 52
Denver 51
Dhaka 51
Haiphong 51
London 51
Pavia 51
Tashkent 50
Willemstad 46
Zhengzhou 46
Verona 45
San Salvador 41
Houston 40
Bologna 39
Warsaw 39
Pune 37
Boston 36
Columbus 36
Stockholm 36
Guatemala City 34
Naples 34
Washington 34
Guayaquil 33
Nairobi 33
Belo Horizonte 32
Amman 31
Newark 31
Orange 31
Brasília 30
Campinas 30
Biên Hòa 29
Brussels 29
Mexico City 29
Totale 41.206
Salva come PNG Salva come JPEG
Nome #
Safety and efficacy of alpha lipoic acid during 4 years of observation: A retrospective, clinical trial in healthy subjects in primary prevention 521
Effetto del lactobacillus paracasei I1688 e del lactobacillus salivarius I1794 (psmix®) sui lipidi ematici nell’ipercolesterolemia lieve 377
Impaired respiratory function reduces haemoglobin oxygen affinity in COVID-19 375
Evaluation of the Effect on Sexual Performance of a Nutraceutical Combination Containing Alpha Lipoic Acid, Vitis vinifera L. and Ginkgo biloba, Compared to Placebo, Avanafil or a Combination of Nutraceutical Plus Avanafil in Males With Type 2 Diabetes Mellitus With Erectile Dysfunction 373
Effects of oral administration of alprazolam and lorazepam as hypnotics on cardiovascular parameters in hypertensive patients. 337
Antiproteinuric effect of telmisartan/amlodipine versus losartan/amlodipine combination in microalbuminuric hypertensive patients with type 2 diabetes 310
Anemia in patients with Covid-19: pathogenesis and clinical significance 300
Atorvastatin addition to losartan or to atenolol and recurrence of paroxysmal atrial fibrillation in hypertension 257
Effect of valsartan addition to amlodipine on ankle oedema and subcutaneous tissue pressure in hypertensive patients 252
Barnidipine or Lercanidipine on Echocardiographic Parameters in Hypertensive, Type 2 Diabetics with Left Ventricular Hypertrophy: A Randomized Clinical Trial 252
A randomized, placebo-controlled study about the effect of a nutraceutical combination of red yeast rice, silybum marianum and octasonol on lipid profile, endothelial and inflammatory parameters 212
Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy 199
Metabolic effect of repaglinide or acarbose when added to a double oral antidiabetic treatment with sulphonylureas and metformin: a double-blind, cross-over, clinical trial 198
Correction to: Anemia in patients with Covid-19: pathogenesis and clinical significance (Clinical and Experimental Medicine, (2021), 10.1007/s10238-020-00679-4) 172
A possible way to improve the glycemic control and the beta cell function during three years: the triple therapy. 164
Correction to: Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy (Internal and Emergency Medicine, (2021), 16, 5, (1141-1152), 10.1007/s11739-020-02550-6) 162
A multicenter, randomised, single-blind study on the effects of exenatide or glimepiride on insulin resistance. 158
An evaluation of a nutraceutical with berberine, curcumin, inositol, banaba and chromium picolinate in patients with fasting dysglycemia 154
A comparison between sitagliptin or glibenclamide in addition to metformin+pioglitazone on glycemic control and beta-cell function: the triple oral therapy 151
A comparison of the effects of pioglitazone and rosiglitazone combined with glimepiride on prothrombotic state in type 2 diabetic patients with the metabolic syndrome 151
Probiotic Therapy With VSL#3® in Patients With NAFLD: A Randomized Clinical Trial 150
Impact of COVID-19 on liver function: results from an internal medicine unit in Northern Italy 150
Evaluation of metalloproteinase 2 and 9 levels and their inhibitors in combined dyslipidemia 148
Abscisic Acid Treatment in Patients with Prediabetes. 147
Comparative effects of telmisartan and eprosartan on insulin sensitivity in the treatment of overweight hypertensive patients 144
Adipocytokines levels in obese and non-obese subjects, an observational study 144
A systematic reviewandmeta-analysis of randomized controlled trials investigating the effects of supplementationwith Nigella sativa (black seed) on blood pressure 144
Different actions of losartan and ramipril on adipose tissue Activity and vascular remodeling biomarkers in hypertensive patients 142
Acarbose on insulin resistance after an oral fat load: a double-blind, placebo controlled study 140
Effects of combination of sibutramine and L-carnitine compared with sibutramine monotherapy on inflammatory parameters in diabetic patients 140
A randomized, double-blind clinical trial of canrenone vs hydrochlorothiazide in addition to angiotensin II receptor blockers in hypertensive type 2 diabetic patients 139
A nutraceutical based approach to reduce cholesterolaemia in patients previously intolerant of more than a statin: a pilot study 139
Confronto tra nateglinide più metformina rispetto a glibenclamide più metformina sul metabolismo glucidico nei pazienti diabetici di tipo 2: studio ad 1 anno 139
A review about biomarkers for the investigation of vascular function and impairment in diabetes mellitus 139
Antiproteinuric effect of telmisartan/amlodipine versus losartan/amlodipine combination in microalbuminuric hypertensive patients with type 2 diabetes 138
Association between low-molecular weight apolipoprotein(a) isoforms and obesity in Italian women 137
Differential effect of glimepiride and rosiglitazone on metabolic control of type 2 diabetic patients treated with metformin: a randomized, double-blind, clinical trial 136
Diagnostico y Tratamiento de los desordenes lipidicos. Mc Graw Hill Education 2014. 136
A randomized, double blind, comparative therapy evaluating sitagliptin versus glibenclamide in type 2 diabetic patients already treated with pioglitazone and metformin: a three years study 135
Acarbose actions on insulin resistance and inflammatory parameters during an oral fat load 135
Azione della moxonidina sul metabolismo glucidico e lipidico negli ipertesi con sindrome metabolica 134
A comparison study of Lp(a) plasma levels distribution between normo and hypertensive subjects with high BMI 134
A randomized, double blind, placebo-controlled trial evaluating sitagliptin action on insulin resistance parameters and β-cell function. 134
Confronto tra pioglitazone e rosiglitazone sul metabolismo glucidico e lipidico nei soggetti diabetici di tipo 2 in terapia con metformina 133
A clinical trial about a food supplement containing α-lipoic acid on oxidative stress markers in type 2 diabetic patients 132
Differential effect of candesartan and olmesartan on adipose tissue activity biomarkers in type 2 diabetic hypertensive patients 131
Atorvastatin-amlodipine combination and fibrinolytic balance in hypertensive hypercholesterolemic insulin-resistent patients 131
Matrix metalloproteinase 2 may be a marker of microangiopathy in children and adolescents with type 1 diabetes 130
Comparison between diet, orlistat and fluvastatin in obese patients with mild hypertension and hypercholesterolemia 130
Effetti metabolici di telmisartan e irbesartan nei pazienti diabetici di tipo 2 con sindrome metabolica trattati con rosiglitazone 130
Actions of glimepiride plus metformin compared to rosiglitazone plus metformin on glucose metabolism, fibrinolytic, and coagulation measurements in Type 2 diabetic patients. 130
Antithrombotic effects of rosiglitazone-metformin versus glimepiride-metformin combination therapy in patients with type 2 diabetes mellitus and metabolic syndrome 129
Diarrea in paziente diabetico 129
Confronto tra candesartan e olmesartan sui parametri correlati alla sensibilità insulinica nei pazienti ipertesi con diabete mellito di tipo 2 129
Effect of valsartan or olmesartan addition to amlodipine/hydrochlorotiazide combination on 24 hour blood pressure reduction in essential hypertension 128
Effetti di pioglitazone e rosiglitazone nei pazienti con diabete di tipo 2 e sindrome metabolica trattati con metformina 127
Confronto tra dieta, orlistat e fluvastatina in soggetti obesi, con ipertensione arteriosa lieve e ipercolesterolemia 127
Effect of telmisartan-amlodipine combination at different doses on urinary albumin excretion in hypertensive diabetic patients with microalbuminuria 126
Effects of berberis aristata/silybum marianum association on metabolic parameters and adipocytokines in overweight dyslipidemic patients 126
Comparison between orlistat plus l-carnitine and orlistat alone on inflammation parameters in obese diabetic patients 125
Comparison between orlistat and sibutramine in obese patients with mild hypertension 125
Acarbose compared to placebo on insulin resistance biomarkers in a double-blind, placebo-controlled trial 125
Effect of delapril-manidipine combination vs irbesartan-hydrochlorothiazide combination on fibrinolytic function in hypertensive patients with type II diabetes mellitus 124
Matrix metalloproteinase 2 may be a marker of microangiopathy compared to metalloproteinase 9 in children and adolescents with type 1 diabetes mellitus: A 5 year follow-up study 124
n-3 Fatty Acids and Cardiovascular Outcomes in Patients with Dysglycemia 124
Effects of 1 year of treatment with pioglitazone or rosiglitazone added to glimepiride on lipoprotein (a) and homocysteine concentrations in patients with type 2 diabetes mellitus and metabolic syndrome: a multicenter, randomized, double-blind, controlled clinical trial 124
Atorvastatin addition to losartan or to atenolol and recurrence of paroxysmal atrial fibrillation in hypertension 123
A randomized, double-blind clinical trial on the long term efficacy of psyllium husk vs. guar gum on the clinical features of metabolic syndrome 123
Variation of inflammatory parameters after sibutramine treatment compared to placebo in type 2 diabetic patients 122
Matrix metalloproteinase-2 activity (MMP-2) in children and adolescents with type 1 diabetes mellitus: Follow-up study 122
Comparison between metalloproteinases-2 and -9 in healthy subjects, diabetics, and subjects with acute coronary syndrome 120
Different aspects of sartan + calcium antagonist association compared to the single therapy on inflammation and metabolic parameters in hypertensive patients 120
A study about the relevance of adding acetylsalicylic acid in primary prevention in subjects with type 2 diabetes mellitus: effects on some new emerging biomarkers of cardiovascular risk 120
Sibutramine effect on metabolic control of obese patients with type 2 diabetes mellitus treated with pioglitazone 119
Effects of sitagliptin or metformin added to pioglitazone monotherapy in poorly controlled type 2 diabetes mellitus patients 118
Differenti effetti di candesartan e olmesartan sui parametri di attività del tessuto adiposo in pazienti diabetici di tipo 2 ipertesi 118
Effetti di un anno di trattamento con vildagliptin associato a pioglitazone o glimepiride in pazienti diabetici scarsamente controllati 117
n-3 PUFAs on metalloproteinases, inflammatory and insulin resistance parameters in dyslipidemic patients after euglycemic clamp and oral fat load. 117
A curious case of hypoglycaemia 117
Aliskiren reduces QT dispersion in hypertensive diabetic patients 117
Comparison of the effects of valsartan and felodipine on plasma leptin and insulin sensitivity in hypertensive obese patients 115
Prevenzione della malattia coronarica: il rischio cardiovascolare globale 115
Berberis aristata combined with Silybum marianum on lipid profile in patients not tolerating statins at high doses. 115
COVID-19 pandemic impact on people with diabetes: results from a large representative sample of Italian older adults 114
Effect of valsartan and ramipril on atrial fibrillation recurrence and P-wave dispersion in hypertensive patients with recurrent symptomatic lone atrial fibrillation 114
Comparison between exenatide and glimepiride on metabolic control and on insulin resistance in type 2 diabetic patients with metformin therapy 114
Comparison between glimepiride plus pioglitazone vs. glimepiride plus rosiglitazone on glucose metabolism and on lipid, lipoprotein and apolipoprotein fractions in type 2 diabetic patients 114
Azione della moxonidina sul metabolismo glucidico e lipidico negli ipertesi con sindrome metabolica 114
Lipoprotein (a) Particles Characterization by Dynamic Light Scattering 114
Comparison between fosinopril and eprosartan on lipid profile and Lp(a) in normotensive, type 2 diabetic subjects, with microalbuminuria 113
A Randomized, Double-Blind, Controlled, Parallel-Group Comparison of Perindopril and Candesartan in Hypertensive Patients with Type 2 Diabetes Mellitus 113
Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study 113
La insulinorresistencia y el sindrome metabolico: de la etiopatogenia a la terapia. 112
Metalloproteasi-2, metalloproteasi-9 ed inibitore tissutale delle metalloproteasi-1 in pazienti ipertesi 112
Alkaloids in the nature: pharmacological applications in clinical practice of berberine and mate tea. 112
The efficacy and safety of pioglitazone or rosiglitazone added onto metformin in type 2 diabetes patients with metabolic syndrome 112
Comparison between orlistat and sibutramine in obese patients with type 2 diabetes mellitus 112
Effect of amlodipine-atorvastatin combination on fibrinolysis in hypertensive hypercholesterolemic insulin-resistant patients 112
Effects of sibutramine plus L-carnitine compared to sibutramine on inflammatory parameters in type 2 diabetic patients 111
High Lp(a) levels and atherogenic isoforms in patients with acute coronary sindrome 111
Totale 15.173
Salva come PNG Salva come JPEG
Categoria #
all - tutte 283.508
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 283.508
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.427 0 0 0 0 11 13 30 162 135 45 480 1.551
2022/20238.600 942 532 47 615 1.009 917 7 537 3.523 96 259 116
2023/20242.641 259 500 95 195 353 653 65 256 28 84 61 92
2024/20258.112 76 807 270 280 146 262 689 756 1.743 123 781 2.179
2025/202618.621 1.383 1.355 2.313 2.041 1.850 777 3.783 786 1.563 1.422 909 439
2026/20276.687 963 1.783 1.336 2.394 211 0 0 0 0 0 0 0
Totale 66.276